Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2021

01-09-2021 | Rectal Cancer | Colorectal Cancer

Endoscopic Feature and Response Reproducibility in Tumor Assessment after Neoadjuvant Therapy for Rectal Adenocarcinoma

Authors: Seth I. Felder, MD, Sujata Patil, Erin Kennedy, Julio Garcia-Aguilar

Published in: Annals of Surgical Oncology | Issue 9/2021

Login to get access

Abstract

Background

The watch-and-wait approach may be safe for selected rectal cancer patients who achieve a complete clinical response after neoadjuvant treatment. Endoscopic examination is critical in determining completeness of tumor response but has not been systematically studied.

Methods

Two cross-sectional surveys, each containing endoscopic photos of rectal cancers treated with neoadjuvant therapy, were distributed to surgeons. The first survey assessed the reproducibility of eight endoscopic criteria using 41 unique endoscopic photos. The percentage of surgeons selecting each of the prespecified endoscopic criteria for each photo was calculated to determine the reproducibility of endoscopic criteria in assessing treatment and tumor response grade across multiple surgeons. The second survey included endoscopic pairs of pre- and post-neoadjuvant treatment photos of 17 patients. The surgeons were assigned a tumor response grade (clinical complete response [cCR], near complete clinical response [nCR], incomplete [iCR] clinical response), and percentages of correct diagnostic assignment were calculated.

Results

The findings showed significant inter- and intra-surgeon variation in the selection of predefined endoscopic features used to grade tumor response as well as significant inter- and intra-surgeon variation in the selection of the tumor response grade (cCR, nCR, or iCR). However, individual endoscopic features and tumor response grades clustered together, suggesting consistency in tumor response interpretation. Surgeons were more accurate in identifying patients with a complete response (82%) than in identifying patients with an incomplete response (68%).

Conclusions

Despite inter- and intra-surgeon variation, endoscopic features were well-selected in terms of tumor response grade, suggesting consistency in endoscopic interpretation. Surgeons tended to underestimate the degree of tumor response, identifying complete responses more accurately than incomplete responses.
Appendix
Available only for authorised users
Literature
6.
go back to reference Dattani M, Heald RJ, Goussous G, Broadhurst J, Sao Juliao GP, Habr-Gama A, et al. Oncological and survival outcomes in watch-and-wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg. 2018;268:955–67. https://doi.org/10.1097/SLA.0000000000002761 (PubMed PMID: 29746338).CrossRefPubMed Dattani M, Heald RJ, Goussous G, Broadhurst J, Sao Juliao GP, Habr-Gama A, et al. Oncological and survival outcomes in watch-and-wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and pooled analysis. Ann Surg. 2018;268:955–67. https://​doi.​org/​10.​1097/​SLA.​0000000000002761​ (PubMed PMID: 29746338).CrossRefPubMed
7.
go back to reference van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391:2537–45. https://doi.org/10.1016/S0140-6736(18)31078-X (PubMed PMID: 29976470).CrossRefPubMed van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018;391:2537–45. https://​doi.​org/​10.​1016/​S0140-6736(18)31078-X (PubMed PMID: 29976470).CrossRefPubMed
10.
go back to reference Battersby NJ, Juul T, Christensen P, Janjua AZ, Branagan G, Emmertsen KJ, et al. United Kingdom Low Anterior Resection Syndrome Study G: predicting the risk of bowel-related quality-of-life impairment after restorative resection for rectal cancer: a multicenter cross-sectional study. Dis Colon Rectum. 2016;59:270–80. https://doi.org/10.1097/DCR.0000000000000552 (PubMed PMID: 26953985).CrossRefPubMed Battersby NJ, Juul T, Christensen P, Janjua AZ, Branagan G, Emmertsen KJ, et al. United Kingdom Low Anterior Resection Syndrome Study G: predicting the risk of bowel-related quality-of-life impairment after restorative resection for rectal cancer: a multicenter cross-sectional study. Dis Colon Rectum. 2016;59:270–80. https://​doi.​org/​10.​1097/​DCR.​0000000000000552​ (PubMed PMID: 26953985).CrossRefPubMed
14.
go back to reference Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, et al. Organ preservation in rectal adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer. 2015;15:767. https://doi.org/10.1186/s12885-015-1632-z (PubMed PMID: 26497495; PMCID: PMC4619249).CrossRefPubMedPubMedCentral Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, Weiser MR, et al. Organ preservation in rectal adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer. 2015;15:767. https://​doi.​org/​10.​1186/​s12885-015-1632-z (PubMed PMID: 26497495; PMCID: PMC4619249).CrossRefPubMedPubMedCentral
Metadata
Title
Endoscopic Feature and Response Reproducibility in Tumor Assessment after Neoadjuvant Therapy for Rectal Adenocarcinoma
Authors
Seth I. Felder, MD
Sujata Patil
Erin Kennedy
Julio Garcia-Aguilar
Publication date
01-09-2021
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 9/2021
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-09827-w

Other articles of this Issue 9/2021

Annals of Surgical Oncology 9/2021 Go to the issue